Longitudinal Association between Serum Leptin Concentration and Glomerular Filtration Rate in Humans

Background Obesity is a risk factor for decline in glomerular filtration rate (GFR). One proposed mechanism leading to glomerulopathy is an increase in leptin levels. However, the association between leptin and GFR has never been demonstrated. The aim of this study is to verify whether higher levels of leptin are associated with longitudinal changes of estimated GFR (eGFR). Methods and findings We selected 744 participants in the InCHIANTI study (416 women). The association between eGFR and leptin changes over a 6-years follow-up was assessed using random effect models including leptin as a time-varying covariate and adjusted for potential confounders. We also compared the proportion of patients with rapid decline of renal function across tertiles of change in serum leptin between baseline and 6-years follow-up. Mean baseline eGFR was 82.2 ml/min/1.73 m, 78.7 ml/min/1.73 m, and 75.4 ml/min/1.73 m in the first, second and third tertile of baseline serum leptin concentration, respectively. After adjustment for potential confounders, leptin concentration was inversely associated with changes of eGFR over time (β for log-leptin: -1.288, 95% CI: -2.079 – -0.497). Relative to baseline levels, the estimated change in eGFR for unit-increase in log-leptin was -1.9% (95% CI: -2.977 – -0.761). After stratification by sex, the results were confirmed in women only. In women we also found an association between increasing leptin concentration over time and rapid decline of renal function. Conclusions In women, serum leptin may contribute to eGFR decline independently from obesity and diabetes mellitus, although a cause-effect relationship cannot be established due to the observational nature of our study. A better characterization of adipokine profile of obese individuals may shed light on the accelerated renal function decline reported in a proportion of high-risk obese individuals.

[1]  Hiroshi Watanabe,et al.  Waist to Height Ratio Is an Independent Predictor for the Incidence of Chronic Kidney Disease , 2014, PloS one.

[2]  J. Kato,et al.  Gender difference in relationship between body mass index and development of chronic kidney disease , 2013, BMC Research Notes.

[3]  Constance M. Park,et al.  Early Improvement in Albuminuria in Non-diabetic Patients after Roux-en-Y Bariatric Surgery , 2012, Obesity Surgery.

[4]  K. Sharma,et al.  Obesity related kidney disease. , 2011, Current Diabetes Reviews.

[5]  Obesity-related renal damage: changing diet to avoid progression. , 2010, Kidney international.

[6]  S. Lydersen,et al.  Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  P. Schauer,et al.  Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[8]  H. Parving,et al.  Microalbuminuria and obesity: impact on cardiovascular disease and mortality , 2009, Clinical endocrinology.

[9]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[10]  Y. Kesäniemi,et al.  Leptin and lipid metabolism in chronic kidney failure , 2009, Scandinavian journal of clinical and laboratory investigation.

[11]  H. Kawachi,et al.  Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases. , 2008, Biochemical and biophysical research communications.

[12]  D. Siscovick,et al.  Rapid kidney function decline and mortality risk in older adults. , 2008, Archives of internal medicine.

[13]  V. Bellizzi,et al.  [Prevalence of chronic kidney disease]. , 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[14]  J. Griffith,et al.  Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  D. Levy,et al.  Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  B. Falkner,et al.  Adiponectin regulates albuminuria and podocyte function in mice. , 2008, The Journal of clinical investigation.

[17]  H. Kramer,et al.  Adverse renal consequences of obesity. , 2008, American journal of physiology. Renal physiology.

[18]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[19]  B. Kestenbaum,et al.  Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. , 2007, Journal of the American Society of Nephrology : JASN.

[20]  G. Wolf,et al.  Leptin and renal fibrosis. , 2006, Contributions to nephrology.

[21]  Carlos Iribarren,et al.  Body Mass Index and Risk for End-Stage Renal Disease , 2006, Annals of Internal Medicine.

[22]  J. Manson,et al.  Association between body mass index and CKD in apparently healthy men. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  A. Luke,et al.  Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  R. Yu,et al.  Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6 , 2005 .

[25]  G. Chertow,et al.  Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. , 2005, Journal of the American Society of Nephrology : JASN.

[26]  N. Patel,et al.  Endogenous Interleukin-6 Enhances the Renal Injury, Dysfunction, and Inflammation Caused by Ischemia/Reperfusion , 2005, Journal of Pharmacology and Experimental Therapeutics.

[27]  R. Yu,et al.  Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. , 2005, Diabetes research and clinical practice.

[28]  S. Kihara,et al.  Adiponectin as a biomarker of the metabolic syndrome. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[29]  K. Iseki,et al.  Body mass index and the risk of development of end-stage renal disease in a screened cohort. , 2004, Kidney international.

[30]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[31]  Neil R. Powe,et al.  Lifestyle Factors, Obesity and the Risk of Chronic Kidney Disease , 2003, Epidemiology.

[32]  T. Weinstein,et al.  The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.

[33]  G. Navis,et al.  A central body fat distribution is related to renal function impairment, even in lean subjects. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[34]  John E. Hall,et al.  Obesity-associated hypertension and kidney disease , 2003, Current opinion in nephrology and hypertension.

[35]  H. Hillege,et al.  Obesity and target organ damage: the kidney , 2002, International Journal of Obesity.

[36]  P. Saha,et al.  Increased β-Oxidation but No Insulin Resistance or Glucose Intolerance in Mice Lacking Adiponectin* , 2002, The Journal of Biological Chemistry.

[37]  M. Esler,et al.  Sympathetic nervous system and insulin resistance: from obesity to diabetes. , 2001, American journal of hypertension.

[38]  S. Bigler,et al.  Functional and structural changes in the kidney in the early stages of obesity. , 2001, Journal of the American Society of Nephrology : JASN.

[39]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[40]  Luigi Ferrucci,et al.  Subsystems Contributing to the Decline in Ability to Walk: Bridging the Gap Between Epidemiology and Geriatric Practice in the InCHIANTI Study , 2000, Journal of the American Geriatrics Society.

[41]  D. Kleinbaum,et al.  Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes. , 2000, American Journal of Kidney Diseases.

[42]  K. Sharma,et al.  Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. , 1997, Kidney international.

[43]  W A Buurman,et al.  Tumor necrosis factor: function, release and clearance. , 1996, Critical reviews in immunology.

[44]  J. Van Snick Interleukin-6: an overview. , 1990, Annual review of immunology.